Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-10-016654
Filing Date
2010-06-07
Accepted
2010-06-07 19:40:43
Documents
1
Period of Report
2010-06-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 19781
  Complete submission text file 0001127602-10-016654.txt   21667
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Issuer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O OSI PHARMACEUTICALS, INC. 58 SOUTH SERVICE ROAD, SUITE 110 MELVILLE NY 11747
Business Address
LUNDEMOSE ANKER MD, PH.D, DSC (Reporting) CIK: 0001314821 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15190 | Film No.: 10882621